Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors.
Ontology highlight
ABSTRACT: To validate a contrast-enhanced CT (CECT)-based radiomics model (RM) for differentiating various risk subgroups of thymic epithelial tumors (TETs). A retrospective study was performed on 164 patients with TETs who underwent CECT scans before treatment. A total of 130 patients (approximately 79%, from 2012 to 2018) were designated as the training set, and 34 patients (approximately 21%, from 2019 to 2021) were designated as the testing set. The analysis of variance and least absolute shrinkage and selection operator algorithm methods were used to select the radiomics features. A logistic regression classifier was constructed to identify various subgroups of TETs. The predictive performance of RMs was evaluated based on receiver operating characteristic (ROC) curve analyses. Two RMs included
SUBMITTER: Yu C
PROVIDER: S-EPMC8898532 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA